1. Home
  2. RGNX vs NAK Comparison

RGNX vs NAK Comparison

Compare RGNX & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • NAK
  • Stock Information
  • Founded
  • RGNX 2008
  • NAK 1983
  • Country
  • RGNX United States
  • NAK Canada
  • Employees
  • RGNX N/A
  • NAK N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • NAK Precious Metals
  • Sector
  • RGNX Health Care
  • NAK Basic Materials
  • Exchange
  • RGNX Nasdaq
  • NAK Nasdaq
  • Market Cap
  • RGNX 356.7M
  • NAK 344.5M
  • IPO Year
  • RGNX 2015
  • NAK 2002
  • Fundamental
  • Price
  • RGNX $7.27
  • NAK $0.66
  • Analyst Decision
  • RGNX Buy
  • NAK Strong Buy
  • Analyst Count
  • RGNX 12
  • NAK 1
  • Target Price
  • RGNX $33.36
  • NAK $1.30
  • AVG Volume (30 Days)
  • RGNX 698.7K
  • NAK 3.7M
  • Earning Date
  • RGNX 02-28-2025
  • NAK 04-01-2025
  • Dividend Yield
  • RGNX N/A
  • NAK N/A
  • EPS Growth
  • RGNX N/A
  • NAK N/A
  • EPS
  • RGNX N/A
  • NAK N/A
  • Revenue
  • RGNX $84,327,000.00
  • NAK N/A
  • Revenue This Year
  • RGNX $2.23
  • NAK N/A
  • Revenue Next Year
  • RGNX $250.77
  • NAK N/A
  • P/E Ratio
  • RGNX N/A
  • NAK N/A
  • Revenue Growth
  • RGNX N/A
  • NAK N/A
  • 52 Week Low
  • RGNX $6.56
  • NAK $0.23
  • 52 Week High
  • RGNX $28.80
  • NAK $0.78
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 41.90
  • NAK 47.10
  • Support Level
  • RGNX $6.92
  • NAK $0.67
  • Resistance Level
  • RGNX $7.79
  • NAK $0.74
  • Average True Range (ATR)
  • RGNX 0.44
  • NAK 0.04
  • MACD
  • RGNX -0.04
  • NAK -0.01
  • Stochastic Oscillator
  • RGNX 19.40
  • NAK 29.82

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About NAK Northern Dynasty Minerals Ltd.

Northern Dynasty Minerals Ltd is a Canadian mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a significant deposit of copper, gold, molybdenum, and silver into a modern mining operation.

Share on Social Networks: